Company Monitoring Page for JNJ

latest headlines for company on cafepharma

J&J’s Auris Has Solid Data to Support Monarch
Medical Devices and Diagnostics Industry
Fri, 10/25/19 - 10:54 pm
Tags:
JNJ, Auris Health, Monarch robots, devices, M&
J&J slashes third-quarter profit by $3 bln over proposed opioid deal
Yahoo/Reuters
Thu, 10/24/19 - 10:28 am
Tags:
JNJ, earnings, opioids, settlements, opioid crisis
Several states wary of $48 billion opioid settlement proposal
Yahoo/Reuters
Thu, 10/24/19 - 10:17 am
Tags:
opioids, opioid crisis, Amerisource Bergen, Cardinal Health, JNJ, Teva Pharmaceutical, McKesson, Ohio, New Hampshire, West Virginia
Provention Bio's J&J-licensed Crohn's drug stumbles in mid-stage study
Endpoints
Wed, 10/23/19 - 10:12 am
Tags:
Provention Bio, JNJ, Crohn's Disease, clinical trials, PRV-6527
Report: Johnson & Johnson CEO ‘Believed’ Baby Powder Was Asbestos-Free 13 Days Before FDA Found Trace Levels
Forbes
Wed, 10/23/19 - 10:07 am
Tags:
JNJ, Alex Gorsky, FDA
Janssen’s Stelara Wins FDA Approval for Ulcerative Colitis
BioSpace
Mon, 10/21/19 - 04:45 pm
Tags:
JNJ, Janssen, Stelara, FDA, ulcerative colitis
J&J’s Tremfya Shows Extended Success in Treating Plaque Psoriasis
BioSpace
Mon, 10/21/19 - 10:00 am
Tags:
JNJ, Janssen, Tremfya, clinical trials, psoriasis
JNJ sheds light on why its settling some opioid cases instead of fighting in court
Yahoo
Sat, 10/19/19 - 01:32 pm
Tags:
JNJ, opioids, opioid crisis, lawsuits
UCB's bispecific beats J&J's Stelara in psoriasis phase 3
Fierce Biotech
Fri, 10/18/19 - 07:47 pm
Tags:
UCB Pharma, bispecific antibodies, bimekizumab, JNJ, Stelara, psoriasis
AbbVie's blockbuster hopeful Rinvoq, J&J's Spravato eye EU rollouts, thanks to new backing
Fierce Pharma
Fri, 10/18/19 - 07:40 pm
Tags:
AbbVie, Rinvoq, Europe, JNJ, Spravato
J&J's Xarelto, Amarin's Vascepa are cost-effective, not budget friendly — ICER
Endpoints
Fri, 10/18/19 - 10:18 am
Tags:
ICER, drug pricing, JNJ, Xarelto, Amarin, Vascepa
J&J Recalls Lot of Baby Powder After Asbestos Trace Found
Yahoo/Bloomberg
Fri, 10/18/19 - 10:14 am
Tags:
JNJ, FDA, product recalls
Is the US opioid litigation nearing an end game?
Pharmaforum
Fri, 10/18/19 - 09:43 am
Tags:
lawsuits, opioids, opioid crisis, JNJ, Teva Pharmaceutical, AmerisourceBergen, Cardinal Health, McKesson
Lawsuit-ridden J&J tumbles in annual listing of best global brands
Fierce Pharma
Thu, 10/17/19 - 10:56 am
Tags:
JNJ, reputation, lawsuits, branding
J&J wins reversal of $110M talc verdict, its 4th appeals win in Missouri
Fierce Pharma
Wed, 10/16/19 - 12:28 pm
Tags:
JNJ, Missouri
Teva, J&J make multibillion-dollar settlement offers as opioid trial gets going
Fierce Pharma
Wed, 10/16/19 - 12:19 pm
Tags:
Teva Pharmaceutical, JNJ, opioids, opioid crisis
Prescription drugs boost drives J&J forecasts higher, shares rise
Yahoo/Reuters
Tue, 10/15/19 - 09:52 am
Tags:
JNJ, earnings, Stelara, Imbruvica
FDA OKs new use for J&J's Xarelto
Seeking Alpha
Mon, 10/14/19 - 09:55 am
Tags:
JNJ, Xarelto, venous thromboembolism, FDA
The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings
Yahoo/Benzinga
Mon, 10/14/19 - 09:43 am
Tags:
JNJ, Flexion Therapeutics, Novartis, Amgen, Clearside Biomedical, Alexion, Assertio Therapeutics, Aldeyra Therapeutics, Lineage Therapeutics, IMMUTEP, Marinus Pharma
Congo to start using J&J Ebola vaccine in November
Yahoo/Reuters
Sun, 10/13/19 - 11:24 pm
Tags:
Congo, JNJ, ebola virus, vaccines

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.